We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00004646
Recruitment Status : Completed
First Posted : February 25, 2000
Last Update Posted : June 24, 2005
National Institute of Neurological Disorders and Stroke (NINDS)
University of Rochester
Information provided by:
Office of Rare Diseases (ORD)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : No date given